The Evolution of Liver Cancer Market in 2024
Join Bloomberg virtually on July 17 as we discuss the current landscape of liver cancer treatment with Dr. Leslie Oleksowicz, who directs a specialized multi-disciplinary hepatocellular cancer program at the University of Cincinnati medical center, including potential advances in the treatment of early stage disease after trial successes from AstraZeneca and Roche and the evolving first line landscape.
Speakers
Max Nisen
Analyst
Bloomberg Intelligence
Leslie Oleksowicz
Director of G.I. Oncology
Member HCC Center of Excellence
Dr. Leslie Oleksowicz is a Professor of Medicine and medical oncologist at St. Louis University Cancer Center. She serves as the center's Director of GI Oncology, including a specialized hepatocellular cancer multi-disciplinary program, and of Immuno-Oncology Research. She is a former NCCN panelist for National Cancer Guidelines and has served as principal investigator in over 300 clinical trials.